Search Platform

All Cases PTAB Litigations UPC Oppositions

Explore PTAB cases, litigation, UPC, and oppositions – All in one place. Find the right case faster with powerful filters and structured results.

CasLoc is a comprehensive patent case research platform that bring together patent case data from multiple jurisdictions into a single streamlined platform. Designed to simplify how legal and IP professionals access, analyze, and track case information. From flexible search to structured case insights, everything is designed to reduce manual effort and helps to focus on analysis and decision-making.

Filters

vs

Filing Date

From

To

Attorney

All Cases Feed

Global Patent Tracker

229 Found <

1 ...

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00722

Filing Date 2026-01-27

Decision Type Final Written Decision: JUDGMENT Final Written Decision on Remand Determining No Challenged Claims Unpatentable 35 U.S.C. §§ 144, 318 Granting Patent Owner’s Motion to Exclude 37 C.F.R. § 42.64(c)

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2026-01-12

Decision Type JUDGMENT Granting Petitioners Joint and Unopposed Motion to Withdraw and Request for Adverse Judgment After Institution of Trial and on Remand 37 C.F.R. § 42.73(b)

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2025-12-09

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00722

Filing Date 2025-07-29

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2025-01-10

Decision Type Termination Decision: Post-DI Settlement

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01226

Filing Date 2024-08-23

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01225

Filing Date 2024-08-23

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2021-00881

Filing Date 2024-07-19

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2021-00880

Filing Date 2024-07-19

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2024-05-28

Decision Type Institution decision and grant of joinder, IPR2024-00107

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2024-04-25

Decision Type Institution decision and grant of joinder, IPR2024-00009

PDF View Details

In Re: Aflibercept Patent Litigation

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 1:24-md-03103

Filing Date 2024-04-11

Cause / Court 28:1338 Patent Infringement

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01226

Filing Date 2024-01-09

Decision Type Final Written Decision: original

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-01225

Filing Date 2024-01-09

Decision Type JUDGMENT Final Written Decision Denying in Part, Granting in Part, and Dismissing in Part Petitioner’s Motion to Exclude Evidence, Denying in Part and Dismissing in Part Patent Owner’s Motion to Exclude Evidence, Determining Challenged Claims 1, 3–11, 13, 14, 16–24, and 26 Unpatentable 35 U.S.C. § 318(a)

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00724

Filing Date 2023-10-04

Decision Type Institution Decision: Grant

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00723

Filing Date 2023-10-02

Decision Type Denying Institution of Inter Partes Review 35 U.S.C. § 314

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00722

Filing Date 2023-10-02

Decision Type Denying Institution of Inter Partes Review 35 U.S.C. § 314

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Bausch Health Ireland Limited et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00722

Filing Date 2023-09-08

Decision Type Final Written Decision: original

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Sanfoi-Aventis Deutschland GmbH

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2019-01657

Filing Date 2023-08-31

Decision Type Other: Fed Circuit mandate

PDF View Details

Mylan Pharmaceuticals Inc. et al. vs. Bayer Pharma AG et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00517

Filing Date 2023-07-28

Decision Type Determining All Challenged Claims Unpatentable 35 U.S.C. § 318(a)

PDF View Details

229 Found <

1 ...